whitelilac
Well-Known Member
- Joined
- Jul 3, 2017
- Messages
- 5,869
- Reaction score
- 63,447
Interesting and encouraging
a coalition of European researchers says that already approved drugs might hold the key to treating the new virus.
“Drug repurposing is a strategy for generating additional value from an existing drug by targeting diseases other than that for which it was originally intended,” said Denis Kainov, the senior author on the paper and an associate professor at the Norwegian University of Science and Technology. “For example, teicoplanin, oritavancin, dalbavancin and monensin are approved antibiotics that have been shown to inhibit corona- and other viruses in the laboratory.”
The researchers reviewed information on the discovery and development of broad-spectrum antiviral agents (BSAAs), which are drugs that target viruses from two or more different viral families. They summarized what they found for 120 drugs that had already been shown to be safe for humans use and created a database, which is freely accessible. Thirty-one of these were found by the researchers to be possible candidates for prophylaxis and treatment of the COVID-19 infections. The researchers also found that clinical investigations have recently begun of five possible drug candidates to treat COVID-19.
more:
Existing Drugs Could Be Key To Combatting Coronavirus Outbreak
a coalition of European researchers says that already approved drugs might hold the key to treating the new virus.
“Drug repurposing is a strategy for generating additional value from an existing drug by targeting diseases other than that for which it was originally intended,” said Denis Kainov, the senior author on the paper and an associate professor at the Norwegian University of Science and Technology. “For example, teicoplanin, oritavancin, dalbavancin and monensin are approved antibiotics that have been shown to inhibit corona- and other viruses in the laboratory.”
The researchers reviewed information on the discovery and development of broad-spectrum antiviral agents (BSAAs), which are drugs that target viruses from two or more different viral families. They summarized what they found for 120 drugs that had already been shown to be safe for humans use and created a database, which is freely accessible. Thirty-one of these were found by the researchers to be possible candidates for prophylaxis and treatment of the COVID-19 infections. The researchers also found that clinical investigations have recently begun of five possible drug candidates to treat COVID-19.
more:
Existing Drugs Could Be Key To Combatting Coronavirus Outbreak
